back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-02-03 17:29 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Shoemaker, Mary
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$303.33
+30,333 vol $0.01 each |
30,333 | |
| Filed 2020-02-03 17:29 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Shoemaker, Mary
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-03 17:29 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Shoemaker, Mary
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-535.00
-53,500 vol $0.01 each |
160,500 | |
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Shoemaker, Mary
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+214,000 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Shoemaker, Mary
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+214,000 vol |
214,000 | |
| Filed 2018-12-27 Tx date 2018-10-16 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Shoemaker, Mary
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-27 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Shoemaker, Mary
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+214,000 vol |
214,000 |